Twist Bioscience Corp (TWST) stock
TWSTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 13/30237% above fair value
$111.60−2.62 (-2.29%)
Close on Nov 13, 2026Market cap $7.00BP/E –Yield –
Twist Bioscience total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Twist Bioscience's total debt was $0 at Sep 30, 2022. For fiscal 2022 it was $0, down 100.0% from the year before. The highest annual figure on record is $9.72M in fiscal 2018.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2022 | Sep 30, 2022 | $0 | -100.0% |
| FY2021 | Sep 30, 2021 | $1.55M | -67.2% |
| FY2020 | Sep 30, 2020 | $4.74M | -38.8% |
| FY2019 | Sep 30, 2019 | $7.73M | -20.4% |
| FY2018 | Sep 30, 2018 | $9.72M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022CQ3 2022 | Sep 30, 2022 | $0 | -100.0% |
| Q3 FY2022CQ2 2022 | Jun 30, 2022 | $0 | -100.0% |
| Q2 FY2022CQ1 2022 | Mar 31, 2022 | $0 | -100.0% |
| Q4 FY2021CQ3 2021 | Sep 30, 2021 | $1.55M | -67.2% |
| Q3 FY2021CQ2 2021 | Jun 30, 2021 | $2.37M | -57.0% |
| Q2 FY2021CQ1 2021 | Mar 31, 2021 | $3.17M | -49.4% |
| Q1 FY2021CQ4 2020 | Dec 31, 2020 | $3.96M | -43.5% |
| Q4 FY2020CQ3 2020 | Sep 30, 2020 | $4.74M | -38.8% |
| Q3 FY2020CQ2 2020 | Jun 30, 2020 | $5.50M | -34.9% |
| Q2 FY2020CQ1 2020 | Mar 31, 2020 | $6.26M | -31.7% |
| Q1 FY2020CQ4 2019 | Dec 31, 2019 | $7.00M | -29.0% |
| Q4 FY2019CQ3 2019 | Sep 30, 2019 | $7.73M | -20.4% |
| Q3 FY2019CQ2 2019 | Jun 30, 2019 | $8.45M | – |
| Q2 FY2019CQ1 2019 | Mar 31, 2019 | $9.16M | – |
| Q1 FY2019CQ4 2018 | Dec 31, 2018 | $9.86M | – |
| Q4 FY2018CQ3 2018 | Sep 30, 2018 | $9.72M | – |
See a number that looks wrong?